Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (491-500 of 514) with videos related to

Pageof 52
Sort By:
Intensive Care Medicine|October 2, 2020
Correction to: Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort studyFernando G Zampieri, Thiago G Romano, Jorge I F Salluh, et al.
Physical Review Letters|July 9, 2020
Search for Nova Presolar Grains: γ-Ray Spectroscopy of ^{34}Ar and its Relevance for the Astrophysical ^{33}Cl(p,γ) ReactionA R L Kennington, G Lotay, D T Doherty, et al.
Physical Review Letters|April 13, 2019
First Observation of Unbound ^{11}O, the Mirror of the Halo Nucleus ^{11}LiT B Webb, S M Wang, K W Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
NPJ Breast Cancer|August 14, 2024
Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancerRenata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, et al.
JAMA Network Open|September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerTomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
JNCI Cancer Spectrum|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsNadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
Breast Cancer Research and Treatment|February 3, 2025
Pathologic complete response rates of patients with ER-low/HER2-negative breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy in the neo-real studyRenata Colombo Bonadio, Monique Celeste Tavares, Flávia Cavalcanti Balint, et al.
Pageof 52

Showing results (491-500 of 514) with videos related to

Sort By:
Pageof 52
Intensive Care Medicine|October 2, 2020
Correction to: Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort studyFernando G Zampieri, Thiago G Romano, Jorge I F Salluh, et al.
Physical Review Letters|July 9, 2020
Search for Nova Presolar Grains: γ-Ray Spectroscopy of ^{34}Ar and its Relevance for the Astrophysical ^{33}Cl(p,γ) ReactionA R L Kennington, G Lotay, D T Doherty, et al.
Physical Review Letters|April 13, 2019
First Observation of Unbound ^{11}O, the Mirror of the Halo Nucleus ^{11}LiT B Webb, S M Wang, K W Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
NPJ Breast Cancer|August 14, 2024
Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancerRenata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, et al.
JAMA Network Open|September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerTomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
JNCI Cancer Spectrum|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsNadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
Breast Cancer Research and Treatment|February 3, 2025
Pathologic complete response rates of patients with ER-low/HER2-negative breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy in the neo-real studyRenata Colombo Bonadio, Monique Celeste Tavares, Flávia Cavalcanti Balint, et al.
Pageof 52